Quantification of ADP and ATP receptor expression in human platelets

Journal of Thrombosis and Haemostasis

Volumn 1, Issue 2, 2003, Pages 330-336

  Wang, L ^a   OStberg O ^a   Wihlborg, A K ^a   Brogren, H ^b   Jerny, S ^b   Erlinge, D ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

P2X receptor; P2Y receptor; Platelets; Real time PCR; Western blot

Indexed keywords

MEMBRANE PROTEIN; MESSENGER RNA; P2RY12 PROTEIN, HUMAN; PRIMER DNA; PURINE P2 RECEPTOR; PURINE P2X1 RECEPTOR; PURINE P2Y1 RECEPTOR; PURINE P2Y12 RECEPTOR;

ARTICLE; CHEMISTRY; GENE EXPRESSION; GENETICS; HUMAN; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THROMBOCYTE; WESTERN BLOTTING;

BASE SEQUENCE; BLOOD PLATELETS; BLOTTING, WESTERN; DNA PRIMERS; GENE EXPRESSION; HUMANS; MEMBRANE PROTEINS; RECEPTORS, PURINERGIC P2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0041442717     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1046/j.1538-7836.2003.00070.x     Document Type: Article

References (32)

1. Gachet C. ADP receptors of platelets and their inhibition. Thromb Haemost 2001; 86: 222-32.
2. Solet DJ, Zacharski LR, Plehn JF. The role of adenosine 5′-diphosphate receptor blockade in patients with cardiovascular disease. Am J Med 2001; 111: 45-53.
3. Gachet C. Platelet activation by ADP. the role of ADP antagonists. Ann Med 2000; 32 (Suppl. 1): 15-20.
4. A. randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet 1996; 348: 1329-39.
5. Kunapuli SP. Multiple P2 receptor subtypes on platelets: a new interpretation of their function. Trends Pharmacol Sci 1998; 19: 391-4.
6. Fabre JE, Nguyen M, Latour A, Keifer JA, Audoly LP, Coffman TM, Koller BH. Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice. Nat Med 1999; 5: 1199-202.
7. Leon C, Freund M, Ravanat C, Baurand A, Cazenave JP, Gachet C. Key role of the P2Y(1) receptor in tissue factor-induced thrombin- dependent acute thromboembolism: studies in P2Y(1)-knockout mice and mice treated with a P2Y(1) antagonist. Circulation 2001; 103: 718-23.
8. North RA, Surprenant A. Pharmacology of cloned P2X receptors. Annu Rev Pharmacol Toxicol 2000; 40: 563-80.
9. Rolf MG, Brearley CA, Mahaut-Smith MP. Platelet shape change evoked by selective activation of P2X1 purinoceptors with alpha,beta-methylene ATP. Thromb Haemost 2001; 85: 303-8.
10. Cusack NJ, Hourani SM. Platelet P2 receptors: from curiosity to clinical targets. J Auton Nerv Syst 2000; 81: 37-43.
11. Sottile J, Mosher DF, Fullenweider J, George JN. Human platelets contain mRNA transcripts for platelet factor 4 and actin. Thromb Haemost 1989; 62: 1100-2.
12. Power CA, Clemetson JM, Clemetson KJ, Wells TN. Chemokine and chemokine receptor mRNA expression in human platelets. Cytokine 1995; 7: 479-82.
13. Lindemann S, Tolley ND, Dixon DA, McIntyre TM, Prescott SM, Zimmerman GA, Weyrich AS. Activated platelets mediate inflammatory signaling by regulated interleukin 1beta synthesis. J Cell Biol 2001; 154: 485-90.
14. Weyrich AS, Dixon DA, Pabla R, Elstad MR, McIntyre TM, Prescott SM, Zimmerman GA. Signal-dependent translation of a regulatory protein, Bcl-3, in activated human platelets. Proc Natl Acad Sci USA 1998; 95: 5556-61.
15. Pabla R, Weyrich AS, Dixon DA, Bray PF, McIntyre TM, Prescott SM, Zimmerman GA. Integrin-dependent control of translation: engagement of integrin alphaIIbbeta3 regulates synthesis of proteins in activated human platelets. J Cell Biol 1999; 144: 175-84.
16. Michelson AD, Barnard MR, Hechtman HB et al. In vivo tracking of platelets: circulating degranulated platelets rapidly lose surface Pselectin but continue to circulate and function. Proc Natl Acad Sci USA 1996; 93: 11877-82.
17. Berger G, Hartwell DW, Wagner DD. P-Selectin and platelet clearance. Blood 1998; 92: 4446-52.
18. Dale GL. Platelet kinetics. Curr Opin Hematol 1997; 4: 330-4.
19. Djaffar I, Vilette D, Bray PF, Rosa JP. Quantitative isolation of RNA from human platelets. Thromb Res 1991; 62: 127-35.
20. Newman PJ, Gorski J, White GC 2nd, Gidwitz S, Cretney CJ, Aster RH. Enzymatic amplification of platelet-specific messenger RNA using the polymerase chain reaction. J Clin Invest 1988; 82: 739-43.
21. Leon C, Hechler B, Vial C, Leray C, Cazenave JP, Gachet C. The P2Y1 receptor is an ADP receptor antagonized by ATP and expressed in platelets and megakaryoblastic cells. FEBS Lett 1997; 403: 26-30.
22. Wang L, Karlsson L, Moses S, Hultgårdh-Nilsson A, Andersson M, Borna C, Gudbjartsson T, Jern S, Erlinge D. P2 Receptor profiles in human vascular smooth muscle and endothelial cells. J Cardiovasc Pharmacol 2002; 40: 841-53.
23. Hoffmann C, Moro S, Nicholas RA, Harden TK, Jacobson KA. The role of amino acids in extracellular loops of the human P2Y1 receptor in surface expression and activation processes. J Biol Chem 1999; 274: 14639-47.
24. Lindemann S, Tolley ND, Eyre JR, Kraiss LW, Mahoney TM, Weyrich AS. Integrins regulate the intracellular distribution of eukaryotic initiation factor 4E in platelets. A checkpoint for translational control. J Biol Chem 2001; 276: 33947-51.
25. Higuchi R, Fockler C, Dollinger G, Watson R. Kinetic PCR analysis. Real-time monitoring of DNA amplification reactions. Biotechnology (NY) 1993; 11: 1026-30.
26. Sun B, Li J, Okahara K, Kambayashi J. P2X1 purinoceptor in human platelets. Molecular cloning and functional characterization after heterologous expression. J Biol Chem 1998; 273: 11544-7.
27. Woulfe D, Yang J, Brass L. ADP and platelets: the end of the beginning. J Clin Invest 2001; 107: 1503-5.
28. Nicholas RA. Identification of the P2Y(12) receptor: a novel member of the P2Y family of receptors activated by extracellular nucleotides. Mol Pharmacol 2001; 60: 416-20.
29. Oury C, Toth-Zsamboki E, Thys C, Tytgat J, Vermylen J, Hoylaerts MF. The ATP-gated P2X1 ion channel acts as a positive regulator of platelet responses to collagen. Thromb Haemost 2001; 86: 1264-71.
30. Vial C, Rolf MG, Mahaut-Smith MP, Evans RJ. A study of P2X(1) receptor function in murine megakaryocytes and human platelets reveals synergy with P2Y receptors. Br J Pharmacol 2002; 135: 363-72.
31. Greco NJ, Tonon G, Chen W, Luo X, Dalal R, Jamieson GA. Novel structurally altered P(2X1) receptor is preferentially activated by adenosine diphosphate in platelets and megakaryocytic cells. Blood 2001; 98: 100-7.
32. Oury C, Toth-Zsamboki E, Van Geet C et al. A natural dominant negative P2X1 receptor due to deletion of a single amino acid residue. J Biol Chem 2000; 275: 22611-4.